Updated Diagnostic Cortisol Values for Adrenal Insufficiency
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT05149638
- Status
- Recruiting
Conditions
- Adrenal Insufficiency
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Cosyntropin stimulation test — DIAGNOSTIC_TESTIn this test, Cosyntropin is administered as an intramuscular injection into the arm. Cortisol levels are measured before and after injection. Cosyntropin tests are routine medical tests that are done in doctors' offices to diagnose adrenal insufficiency. Cosyntropin is a synthetic version of a hormone, called ACTH, that is secreted by our bodies to help produce cortisol.
Study Details
The purpose of this study is to determine the cortisol levels that most accurately diagnose a patient with adrenal insufficiency, a condition in which cortisol levels are too low for daily living.
Key Dates
- Start date
- Feb 3, 2022
- Status verified
- Feb 2026
- Primary completion
- Dec 1, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Active Comparator: Healthy volunteersHealthy volunteers are those 18 years or older without prior diagnosis of adrenal insufficiency. Study participation by healthy volunteers helps us understand what cortisol levels should be in a healthy population. This information also helps us figure out what levels might be in people with adrenal insufficiency.
- Active Comparator: Patients with known adrenal insufficiencyThis group consists of patients 18 years or older with an established diagnosis of adrenal insufficiency. Study participation by patients with adrenal insufficiency helps us understand what cortisol levels should be, in the new assays, among those with adrenal insufficiency.
- Active Comparator: Patients suspected to have adrenal insufficiencyThis groups consists of patients 18 years or older who are suspected to have adrenal insufficiency. Study participation by this group will help us understand if the cortisol values we get from the new assay accurately diagnose adrenal insufficiency.
Primary Outcome Measure
Cortisol threshold with cosyntropin stimulation test [ Time Frame: 0 minutes (pre-cosyntropin administration) and 30 and 60 minutes post-cosyntropin administration; up to 2 hours participation time ]
Central Contacts
- Smita B Abraham, MD718-839-7322
- Noah Bloomgarden, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 | Smita Abraham, MD Noah Bloomgarden, MD Smita Abraham, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in The Bronx, NY
By research site
Related Studies
- Evaluation of Children With Endocrine and Metabolic-Related ConditionsRecruiting · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Bethesda, Maryland
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid ReplacementRecruiting · University of Michigan · Ann Arbor, Michigan